Combining TIGIT blockade with IL‐15 stimulation is a promising immunotherapy strategy for lung adenocarcinoma.
Saved in:
| Title: | Combining TIGIT blockade with IL‐15 stimulation is a promising immunotherapy strategy for lung adenocarcinoma. |
|---|---|
| Authors: | Luo, Baohong1 (AUTHOR), Sun, Yu1,2 (AUTHOR), Zhan, Qinru1,2 (AUTHOR), Luo, Yuting1,2 (AUTHOR), Chen, Yu2,3 (AUTHOR), Fu, Tongze1,2 (AUTHOR), Yang, Tiantian1,2 (AUTHOR), Ren, Lijuan1,2 (AUTHOR), Xie, Zhongpeng1,2 (AUTHOR), Situ, Xiaohua1,2 (AUTHOR), Liu, Bixia1 (AUTHOR), Tang, Kejing4 (AUTHOR) tangkj@mail.sysu.edu.cn, Ke, Zunfu1,2 (AUTHOR) kezunfu@mail.sysu.edu.cn |
| Source: | Clinical & Translational Medicine. Jan2024, Vol. 14 Issue 1, p1-20. 20p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20011326 |
|---|---|
| DOI: | 10.1002/ctm2.1553 |